Skip to content
OpenCapital
Get started

Sanara MedTech Inc. SMTI Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

Bioventus logo
BioventusBVS
$45.36M+21.5%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
——
Medtronic logo
MedtronicMDT
——

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S2×-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s noncontrolling interests in subsidiaries?
Sanara MedTech Inc. (SMTI) reported noncontrolling interests in subsidiaries of -$9.02K in Q1 2026.
How has Sanara MedTech Inc.'s noncontrolling interests in subsidiaries changed year-over-year?
Sanara MedTech Inc.'s noncontrolling interests in subsidiaries decreased by 162.9% year-over-year, from -$3.43K to -$9.02K.
What is the long-term trend for Sanara MedTech Inc.'s noncontrolling interests in subsidiaries?
Over 5 years (2020 to 2025), Sanara MedTech Inc.'s noncontrolling interests in subsidiaries has grown at a -51.1% compound annual growth rate (CAGR), from -$310.4K to -$8.67K.
What does noncontrolling interests in subsidiaries mean?
This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.